107 related articles for article (PubMed ID: 29448617)
1. Microquantitation of Prostate-Speciflc Antigen by Using Antibody-Conjugated Magnetic Microsphere Beads.
Lee SD; Lee M; Park SY; Ha Y; Jung SC; Kim H
J Nanosci Nanotechnol; 2018 Feb; 18(2):1474-1477. PubMed ID: 29448617
[TBL] [Abstract][Full Text] [Related]
2. [The usefulness of prostate-specific antigen assay for the early detection and follow up of the prostate cancer].
Saito Y
Nihon Rinsho; 1998 Aug; 56(8):1989-93. PubMed ID: 9750493
[TBL] [Abstract][Full Text] [Related]
3. Enhanced detection sensitivity of prostate-specific antigen via PSA-conjugated gold nanoparticles based on localized surface plasmon resonance: GNP-coated anti-PSA/LSPR as a novel approach for the identification of prostate anomalies.
Jazayeri MH; Amani H; Pourfatollah AA; Avan A; Ferns GA; Pazoki-Toroudi H
Cancer Gene Ther; 2016 Oct; 23(10):365-369. PubMed ID: 27740614
[TBL] [Abstract][Full Text] [Related]
4. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
[TBL] [Abstract][Full Text] [Related]
5. An endoglycosidase-assisted LC-MS/MS-based strategy for the analysis of site-specific core-fucosylation of low-concentrated glycoproteins in human serum using prostate-specific antigen (PSA) as example.
Lang R; Leinenbach A; Karl J; Swiatek-de Lange M; Kobold U; Vogeser M
Clin Chim Acta; 2018 May; 480():1-8. PubMed ID: 29408166
[TBL] [Abstract][Full Text] [Related]
6. Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models.
Denmeade SR; Sokoll LJ; Chan DW; Khan SR; Isaacs JT
Prostate; 2001 Jun; 48(1):1-6. PubMed ID: 11391681
[TBL] [Abstract][Full Text] [Related]
7. ErbB-2 signaling is involved in regulating PSA secretion in androgen-independent human prostate cancer LNCaP C-81 cells.
Lee MS; Igawa T; Yuan TC; Zhang XQ; Lin FF; Lin MF
Oncogene; 2003 Feb; 22(5):781-96. PubMed ID: 12569372
[TBL] [Abstract][Full Text] [Related]
8. Development of a Multiplex Bead-Based Method for the Microquantitation of
Lee M; Taş İ; Zhou R; Jung SC; Kim K; Kim H
J Nanosci Nanotechnol; 2020 Sep; 20(9):5819-5822. PubMed ID: 32331188
[No Abstract] [Full Text] [Related]
9. [Enzyme-linked immunosorbent assay for serum prostate specific antigen (PSA) using monoclonal antibodies].
Setoguchi C; Matsumoto K; Samori T; Kimura E; Harukaze S
Rinsho Byori; 1998 Jan; 46(1):79-82. PubMed ID: 9492543
[TBL] [Abstract][Full Text] [Related]
10. Autocrine regulation of prostate-specific antigen gene expression in a human prostatic cancer (LNCaP) subline.
Hsieh JT; Wu HC; Gleave ME; von Eschenbach AC; Chung LW
Cancer Res; 1993 Jun; 53(12):2852-7. PubMed ID: 7684949
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic potential of prostate-specific antigen expressing epithelial cells in blood of prostate cancer patients.
Gao CL; Rawal SK; Sun L; Ali A; Connelly RR; Bañez LL; Sesterhenn IA; McLeod DG; Moul JW; Srivastava S
Clin Cancer Res; 2003 Jul; 9(7):2545-50. PubMed ID: 12855629
[TBL] [Abstract][Full Text] [Related]
12. [Prostate-specific antigen as a tumor marker of prostate carcinoma].
Wymenga LF; Mensink HJ
Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1733-8. PubMed ID: 10494319
[TBL] [Abstract][Full Text] [Related]
13. Sample preparation of serum to allow capillary electrophoresis analysis of prostate specific antigen isoforms.
Farina-Gomez N; Barrabes S; Gomez-Lopez JE; Gonzalez M; Puerta A; Navarro-Calderon D; Albers-Acosta E; Olivier C; Diez-Masa JC; Peracaula R; de Frutos M
J Pharm Biomed Anal; 2017 Feb; 134():220-227. PubMed ID: 27918991
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer.
Roberts MJ; Chow CW; Schirra HJ; Richards R; Buck M; Selth LA; Doi SA; Samaratunga H; Perry-Keene J; Payton D; Yaxley J; Lavin MF; Gardiner RA
Prostate; 2015 Apr; 75(5):539-49. PubMed ID: 25597828
[TBL] [Abstract][Full Text] [Related]
15. Intravenous injection of an immunoconjugate (anti-PSA-IgG conjugated to 5-fluoro-2'-deoxyuridine) selectively inhibits cell proliferation and induces cell death in human prostate cancer cell tumors grown in nude mice.
Sinha AA; Quast BJ; Reddy PK; Elson MK; Wilson MJ
Anticancer Res; 1999; 19(2A):893-902. PubMed ID: 10368631
[TBL] [Abstract][Full Text] [Related]
16. Prostate-specific antigen and the early diagnosis of prostate cancer.
Caplan A; Kratz A
Am J Clin Pathol; 2002 Jun; 117 Suppl():S104-8. PubMed ID: 14569806
[TBL] [Abstract][Full Text] [Related]
17. Quantitative real-time rt-PCR for detection of circulating prostate-specific antigen mRNA using sequence-specific oligonucleotide hybridization probes in prostate cancer patients.
Straub B; Müller M; Krause H; Schrader M; Miller K
Oncology; 2003; 65 Suppl 1():12-7. PubMed ID: 12949428
[TBL] [Abstract][Full Text] [Related]
18. Role of Magnetic Resonance Imaging in Prostate Cancer Screening: A Pilot Study Within the Göteborg Randomised Screening Trial.
Grenabo Bergdahl A; Wilderäng U; Aus G; Carlsson S; Damber JE; Frånlund M; Geterud K; Khatami A; Socratous A; Stranne J; Hellström M; Hugosson J
Eur Urol; 2016 Oct; 70(4):566-573. PubMed ID: 26724840
[TBL] [Abstract][Full Text] [Related]
19. Sensitive identification of prostate-specific antigen by iron oxide nanoparticle antibody conjugates on the gap-finger electrode surface.
Zhang W; Li K; Guo J; Ma T; Wang D; Shi S; Gopinath SCB; Gu D
Biotechnol Appl Biochem; 2021 Aug; 68(4):896-901. PubMed ID: 32822079
[TBL] [Abstract][Full Text] [Related]
20. [Prostate cancer].
Uchida K; Akaza H
Gan To Kagaku Ryoho; 2001 Oct; 28(10):1469-74. PubMed ID: 11681260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
